NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary. Washington (DC): National Academies Press (US); 2011.

Cover of Building a National Framework for the Establishment of Regulatory Science for Drug Development

Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary.

Show details

References

  1. CDC (Centers for Disease Control and Prevention) About CDC. 2009. [accessed August 2, 2010]. http://www​.cdc.gov/about​/stateofcdc/html/2008/AboutTopic.htm.
  2. FDA (Food and Drug Administration) Remarks of Margaret A. Hamburg, M.D., Commissioner of Food and Drugs at AAAS: The Future of Personalized Medicine, October 26, 2009. 2009. [accessed May 24, 2010]. http://www​.fda.gov/NewsEvents​/Speeches/ucm191356.htm.
  3. FDA. President’s Fiscal Year 2011 Budget Request for the FDA. 2010. [accessed June 4, 2010]. http://www​.fda.gov/NewsEvents​/Testimony/ucm204399.htm.
  4. FDA. Science Board to the Food and Drug Administration. 2010. [accessed March 15, 2010]. http://www​.fda.gov.
  5. FDA. NIH and FDA Announce Collaborative Initiative to Fast-Track Innovations to the Public. 2010. [accessed May 24, 2010]. http://www​.fda.gov/NewsEvents​/Newsroom/PressAnnouncements​/ucm201706.htm.
  6. FDA. Fast Track, Accelerated Approval and Priority Review. 2010. [accessed May 24, 2010]. http://www​.fda.gov/forconsumers​/byaudience​/forpatientadvocates​/speedingaccesstoimportantnewtherapies/ucm128291.htm.
  7. FDA. How Many People Are Employed by FDA and in What Areas Do They Work? 2010. [accessed August 5, 2010]. http://www​.fda.gov/AboutFDA​/Transparency/Basics/ucm213161​.htm.
  8. FDA. FDA Beyond Our Borders. 2010. [accessed August 5, 2010]. http://www​.fda.gov/ForConsumers​/ConsumerUpdates/ucm103036​.htm.
  9. FDA Science Board. FDA Science and Mission at Risk. Rockville, MD: Report of the Subcommittee on Science and Technology; 2007.
  10. FitzGerald G. Regulatory Science and FDA. 2010. [accessed March 19, 2010]. http://iom​.edu/~/media​/Files/Activity%20Files​/Research/DrugForum​/2010-FEB-26/Microsoft​%20PowerPoint%20-​%20FitzGerald-IOMFDA.ashx.
  11. GAO (Government Accountability Office) Medical Devices: FDA Should Take Steps to Ensure That High-Risk Device Types Are Approved Through the Most Stringent Premarket Review Process. GAO-09-190. Washington, DC: GAO; 2009.
  12. Grossman Steven. Top 10 Things That Hill Staff Need to Know About FDA. 2010. [accessed August 2, 2010]. http:​//strengthenfda​.org/2010/03/06/top-10-​%E2%80%9Cthings-that-hill-staff-need-to-know-about-fda​%E2%80%9D/
  13. Harrill AH, Watkins PB, Su S, Ross PK, Harbourt DE, Stylianou IM, Boorman GA, Russo MW, Sackler RS, Harris SC, Smith PC, Tennant R, Bogue M, Paigen K, Harris C, Contractor T, Wiltshire T, Rusyn I, Threadgill DW. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. Genome Research. 2009;19(9):1507–1515. [PMC free article: PMC2752130] [PubMed: 19416960]
  14. HHS (Department of Health and Human Services) Advancing the Health, Safety, and Well-Being of Our People. 2010. [accessed December 21, 2010]. http://www​.hhs.gov/asrt​/ob/docbudget/2011budgetin-brief.pdf.
  15. IOM (Institute of Medicine) The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: The National Academies Press; 2007.
  16. IOM. Emerging Safety Science. Washington, DC: The National Academies Press; 2008.
  17. IOTF (Interagency Oncology Task Force) Joint Fellowship Program. 2010. [accessed May 26, 2010]. http://iotftraining​.nci.nih.gov/
  18. Kim S. Model of Data Sharing in IIRIS/COE. 2010. [accessed March 19, 2010]. http://iom​.edu/~/media​/Files/Activity%20Files​/Research/DrugForum​/2010-FEB-26/Microsoft​%20PowerPoint%20-​%20Kim-IOM-2010-02-26​%20FDA%20Centers%20of%20Excellence​.ashx.
  19. NCI (National Cancer Institute) Clinical Trials Cooperative Group Program. 2010. [accessed May 26, 2010]. http://www​.cancer.gov​/cancertopics/factsheet​/NCI/clinical-trials-cooperative-group.
  20. NIH (National Institutes of Health) NIH and FDA Announce Collaborative Initiative to Fast-Track Innovations to the Public. 2010. [accessed August 5, 2010]. http://www​.nih.gov/news​/health/feb2010/od-24.htm.
  21. Nordenberg D. Centers of Excellence in Regulatory Science Network. 2010. [accessed March 19, 2010]. http://iom​.edu/~/media​/Files/Activity%20Files​/Research/DrugForum​/2010-FEB-26/Microsoft​%20PowerPoint%20​%20NordenbergIOM%20Ctrs​%20of%20Excellence​%20Feb%2026%202010%20v24.ashx.
  22. OMOP (Observational Medical Outcomes Partnership) About Us. 2010. [accessed March 26, 2010]. http://omop​.fnih.org.
  23. Peck C. Centers of Excellence (COEs) in Regulatory and Information Science: Accelerating Development of Innovative Products and Ensuring the Public’s Health, Unpublished paper submitted to IOM Forum on Drug Discovery, Development, and Translation. 2010.
  24. Research!America. America Speaks. 2010. [accessed March 19, 2010]. http://www​.researchamerica​.org/uploads/AmericaSpeaksV10.pdf.
  25. Roses A. IOM 26 Feb 2010 FDA Centers of Excellence for Regulatory Science. 2010. [accessed August 9, 2010]. http://iom​.edu/~/media​/Files/Activity%20Files​/Research/DrugForum​/2010-FEB-26/Microsoft​%20PowerPoint%20-%20Roses.pdf.
  26. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer’s Disease. Pharmacogenomics J. 2009 [PMC free article: PMC2946560] [PubMed: 20029386] [Cross Ref]
  27. The Scientist. More Regulatory Science—FDA Chief. 2009. [accessed May 24, 2010]. http://www​.the-scientist​.com/blog/display/55984/
  28. Sigal E. Opportunities for Enhancing Regulatory Science: A Blueprint to Benefit Patients. 2010. [accessed March 19, 2010]. http://iom​.edu/~/media​/Files/Activity%20Files​/Research/DrugForum​/2010-FEB-26/Microsoft​%20PowerPoint%20-​%20Sigal-IOM%20Reg%20Science%20FINAL​.ashx.
  29. Skarke C, FitzGerald GA. Training translators for smart drug discovery. Science Translational Medicine. 2010;2(26):26cm12. [PubMed: 20375362]
  30. USC (University of Southern California) Frequently Asked Questions—Regarding the Program. 2010. [accessed May 24, 2010]. http://regulatory​.usc.edu/help.aspx#q1.
  31. Wagner JA, Wright EC, Ennis MM, Prince M, Kochan J, Nunez DJR, Schneider B, Wang MD, Chen Y, Ghosh S, Musser BJ, Vassileva MT. Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clinical Pharmacology and Therapeutics. 2009;86(6):619–625. [PubMed: 19553931]
  32. White House. Making Moves for a Healthier Generation. 2010. [accessed June 4, 2010]. http://www​.whitehouse​.gov/blog/2010/02/09​/making-moves-a-healthier-generation.
Copyright © 2011, National Academy of Sciences.
Bookshelf ID: NBK54407
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (974K)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...